10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001140859-21-000005 |
| Period End Date | 20201231 |
| Filing Date | 20210204 |
| Fiscal Year | 2021 |
| Fiscal Period | Q1 |
| XBRL Instance | abc-20201231_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowances for returns and doubtful accounts |
AllowancesForReturnsAndDoubtfulAccounts
|
$1.42B | USD | Point-in-time |
| Allowances for returns and doubtful accounts |
AllowancesForReturnsAndDoubtfulAccounts
|
$1.30B | USD | Point-in-time |
| Common stock, par value (usd per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (usd per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, authorized (shares) |
CommonStockSharesAuthorized
|
600.00M | shares | Point-in-time |
| Common stock, authorized (shares) |
CommonStockSharesAuthorized
|
600.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.60B | USD | Point-in-time |
| Cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.23B | USD | Point-in-time |
| Cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.89B | USD | Point-in-time |
| Cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.37B | USD | Point-in-time |
| Common stock, issued (shares) |
CommonStockSharesIssued
|
287.79M | shares | Point-in-time |
| Accounts receivable, less allowances for returns and doubtful accounts: $1,299,459 as of December 31, 2020 and $1,417,308 as of September 30, 2020 |
AccountsReceivableNetCurrent
|
$14.89B | USD | Point-in-time |
| Common stock, issued (shares) |
CommonStockSharesIssued
|
289.12M | shares | Point-in-time |
| Accounts receivable, less allowances for returns and doubtful accounts: $1,299,459 as of December 31, 2020 and $1,417,308 as of September 30, 2020 |
AccountsReceivableNetCurrent
|
$13.85B | USD | Point-in-time |
| Common stock, outstanding (shares) |
CommonStockSharesOutstanding
|
204.23M | shares | Point-in-time |
| Inventories |
InventoryNet
|
$13.18B | USD | Point-in-time |
| Common stock, outstanding (shares) |
CommonStockSharesOutstanding
|
204.69M | shares | Point-in-time |
| Inventories |
InventoryNet
|
$12.59B | USD | Point-in-time |
| Right to recover assets |
ContractWithCustomerAssetGrossCurrent
|
$1.34B | USD | Point-in-time |
| Right to recover assets |
ContractWithCustomerAssetGrossCurrent
|
$1.19B | USD | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
83.56M | shares | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
84.42M | shares | Point-in-time |
| Income tax receivable |
IncomeTaxesReceivable
|
$488.43M | USD | Point-in-time |
| Income tax receivable |
IncomeTaxesReceivable
|
$317.66M | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssetsCurrent
|
$234.67M | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssetsCurrent
|
$189.30M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$33.06B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$34.70B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.48B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.48B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.71B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.71B | USD | Point-in-time |
| Other intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$1.86B | USD | Point-in-time |
| Other intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$1.89B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$326.82M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$361.64M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$771.03M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$779.85M | USD | Point-in-time |
| TOTAL ASSETS |
Assets
|
$45.85B | USD | Point-in-time |
| TOTAL ASSETS |
Assets
|
$44.27B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$31.71B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$33.45B | USD | Point-in-time |
| Accrued expenses and other |
AccruedLiabilitiesCurrent
|
$1.54B | USD | Point-in-time |
| Accrued expenses and other |
AccruedLiabilitiesCurrent
|
$1.65B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$59.37M | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$501.26M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$33.85B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$35.04B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$3.62B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$3.64B | USD | Point-in-time |
| Accrued income taxes |
AccruedIncomeTaxesNoncurrent
|
$287.24M | USD | Point-in-time |
| Accrued income taxes |
AccruedIncomeTaxesNoncurrent
|
$284.85M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$703.65M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$686.49M | USD | Point-in-time |
| Accrued litigation liability |
LitigationReserveNoncurrent
|
$6.20B | USD | Point-in-time |
| Accrued litigation liability |
LitigationReserveNoncurrent
|
$6.20B | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$472.86M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$483.29M | USD | Point-in-time |
| Commitments and contingencies (Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 289,115,051 shares, and 204,692,947 shares as of December 31, 2020, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively |
CommonStockValue
|
$2.88M | USD | Point-in-time |
| Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 289,115,051 shares, and 204,692,947 shares as of December 31, 2020, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively |
CommonStockValue
|
$2.89M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$5.19B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$5.08B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$780.97M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$518.34M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-70.47M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-108.83M | USD | Point-in-time |
| Treasury stock, at cost: 84,422,104 shares as of December 31, 2020 and 83,564,014 shares as of September 30, 2020 |
TreasuryStockValue
|
$6.51B | USD | Point-in-time |
| Treasury stock, at cost: 84,422,104 shares as of December 31, 2020 and 83,564,014 shares as of September 30, 2020 |
TreasuryStockValue
|
$6.60B | USD | Point-in-time |
| Total AmerisourceBergen Corporation stockholders' deficit |
StockholdersEquity
|
$-697.22M | USD | Point-in-time |
| Total AmerisourceBergen Corporation stockholders' deficit |
StockholdersEquity
|
$-1.02B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$179.29M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$185.67M | USD | Point-in-time |
| Total deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Total deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.07B | USD | Point-in-time |
| Total deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Total deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-511.55M | USD | Point-in-time |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT |
LiabilitiesAndStockholdersEquity
|
$45.85B | USD | Point-in-time |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT |
LiabilitiesAndStockholdersEquity
|
$44.27B | USD | Point-in-time |
Income Statement
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue |
Revenues
|
$52.52B | USD | 1 Quarter |
| Revenue |
Revenues
|
$47.86B | USD | 1 Quarter |
| Cost of goods sold |
CostOfGoodsAndServicesSold
|
$46.63B | USD | 1 Quarter |
| Cost of goods sold |
CostOfGoodsAndServicesSold
|
$51.06B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.45B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.23B | USD | 1 Quarter |
| Distribution, selling, and administrative |
SellingGeneralAndAdministrativeExpense
|
$685.95M | USD | 1 Quarter |
| Distribution, selling, and administrative |
SellingGeneralAndAdministrativeExpense
|
$735.07M | USD | 1 Quarter |
| Depreciation |
DepreciationNonproduction
|
$69.24M | USD | 1 Quarter |
| Depreciation |
DepreciationNonproduction
|
$73.94M | USD | 1 Quarter |
| Amortization |
AmortizationOfIntangibleAssets
|
$35.27M | USD | 1 Quarter |
| Amortization |
AmortizationOfIntangibleAssets
|
$25.61M | USD | 1 Quarter |
| Employee severance, litigation, and other |
RestructuringCharges
|
$70.38M | USD | 1 Quarter |
| Employee severance, litigation, and other |
RestructuringCharges
|
$39.31M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
AssetImpairmentCharges
|
$138.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
AssetImpairmentCharges
|
- | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$263.44M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$547.23M | USD | 1 Quarter |
| Other (income) loss, net |
NonoperatingIncomeExpense
|
$-2.84M | USD | 1 Quarter |
| Other (income) loss, net |
NonoperatingIncomeExpense
|
$14.27M | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-33.61M | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-31.01M | USD | 1 Quarter |
| Income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$229.59M | USD | 1 Quarter |
| Income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$527.88M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$149.18M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$43.02M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$378.71M | USD | 1 Quarter |
| Net (income) loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.07M | USD | 1 Quarter |
| Net (income) loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$3.86M | USD | 1 Quarter |
| Net income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$374.85M | USD | 1 Quarter |
| Net income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$187.64M | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$0.91 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$1.83 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$1.81 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$0.90 | USD | 1 Quarter |
| Basic (shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
204.68M | shares | 1 Quarter |
| Basic (shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
206.01M | shares | 1 Quarter |
| Diluted (shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
206.80M | shares | 1 Quarter |
| Diluted (shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
207.52M | shares | 1 Quarter |
| Cash dividends declared per share of common stock (usd per share) |
CommonStockDividendsPerShareDeclared
|
$0.44 | USD | 1 Quarter |
| Cash dividends declared per share of common stock (usd per share) |
CommonStockDividendsPerShareDeclared
|
$0.40 | USD | 1 Quarter |
Cash Flow Statement
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$378.71M | USD | 1 Quarter |
| Depreciation, including amounts charged to cost of goods sold |
Depreciation
|
$71.85M | USD | 1 Quarter |
| Depreciation, including amounts charged to cost of goods sold |
Depreciation
|
$77.14M | USD | 1 Quarter |
| Amortization, including amounts charged to interest expense |
AdjustmentForAmortization
|
$37.50M | USD | 1 Quarter |
| Amortization, including amounts charged to interest expense |
AdjustmentForAmortization
|
$27.14M | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$6.45M | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$2.19M | USD | 1 Quarter |
| Provision for deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$29.36M | USD | 1 Quarter |
| Provision for deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$72.91M | USD | 1 Quarter |
| Share-based compensation |
ShareBasedCompensation
|
$48.32M | USD | 1 Quarter |
| Share-based compensation |
ShareBasedCompensation
|
$31.37M | USD | 1 Quarter |
| LIFO (credit) expense |
InventoryLIFOReservePeriodCharge
|
$13.28M | USD | 1 Quarter |
| LIFO (credit) expense |
InventoryLIFOReservePeriodCharge
|
$-25.73M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
AssetImpairmentCharges
|
$138.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
AssetImpairmentCharges
|
- | USD | 1 Quarter |
| Other, net |
OtherNoncashIncomeExpense
|
$-28.48M | USD | 1 Quarter |
| Other, net |
OtherNoncashIncomeExpense
|
$-17.48M | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$906.50M | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$307.20M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$545.46M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$630.98M | USD | 1 Quarter |
| Income taxes receivable |
IncreaseDecreaseInIncomeTaxesReceivable
|
$-170.77M | USD | 1 Quarter |
| Income taxes receivable |
IncreaseDecreaseInIncomeTaxesReceivable
|
$1.47M | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$3.12M | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-1.36M | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$787.04M | USD | 1 Quarter |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.72B | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-8.09M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$1.67M | USD | 1 Quarter |
| Accrued expenses and other liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$-139.47M | USD | 1 Quarter |
| Accrued expenses and other liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$-235.19M | USD | 1 Quarter |
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
NetCashProvidedByUsedInOperatingActivities
|
$142.81M | USD | 1 Quarter |
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
NetCashProvidedByUsedInOperatingActivities
|
$903.05M | USD | 1 Quarter |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$67.31M | USD | 1 Quarter |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$65.41M | USD | 1 Quarter |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
- | USD | 1 Quarter |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-4.97M | USD | 1 Quarter |
| NET CASH USED IN INVESTING ACTIVITIES |
NetCashProvidedByUsedInInvestingActivities
|
$-62.34M | USD | 1 Quarter |
| NET CASH USED IN INVESTING ACTIVITIES |
NetCashProvidedByUsedInInvestingActivities
|
$-65.41M | USD | 1 Quarter |
| Loan borrowings |
ProceedsFromIssuanceOfDebt
|
$18.54M | USD | 1 Quarter |
| Loan borrowings |
ProceedsFromIssuanceOfDebt
|
$31.39M | USD | 1 Quarter |
| Loan repayments |
RepaymentsOfDebt
|
$462.64M | USD | 1 Quarter |
| Loan repayments |
RepaymentsOfDebt
|
$29.02M | USD | 1 Quarter |
| Borrowings under revolving and securitization credit facilities |
ProceedsFromLinesOfCredit
|
- | USD | 1 Quarter |
| Borrowings under revolving and securitization credit facilities |
ProceedsFromLinesOfCredit
|
$50.58M | USD | 1 Quarter |
| Repayments under revolving and securitization credit facilities |
RepaymentsOfLinesOfCredit
|
- | USD | 1 Quarter |
| Repayments under revolving and securitization credit facilities |
RepaymentsOfLinesOfCredit
|
$54.08M | USD | 1 Quarter |
| Purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$135.13M | USD | 1 Quarter |
| Purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$56.17M | USD | 1 Quarter |
| Exercises of stock options |
ProceedsFromStockOptionsExercised
|
$58.22M | USD | 1 Quarter |
| Exercises of stock options |
ProceedsFromStockOptionsExercised
|
$20.11M | USD | 1 Quarter |
| Cash dividends on common stock |
PaymentsOfDividendsCommonStock
|
$91.10M | USD | 1 Quarter |
| Cash dividends on common stock |
PaymentsOfDividendsCommonStock
|
$83.09M | USD | 1 Quarter |
| Tax withholdings related to restricted share vesting |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$23.25M | USD | 1 Quarter |
| Tax withholdings related to restricted share vesting |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$9.60M | USD | 1 Quarter |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-910.00K | USD | 1 Quarter |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-381.00K | USD | 1 Quarter |
| NET CASH USED IN FINANCING ACTIVITIES |
NetCashProvidedByUsedInFinancingActivities
|
$-222.06M | USD | 1 Quarter |
| NET CASH USED IN FINANCING ACTIVITIES |
NetCashProvidedByUsedInFinancingActivities
|
$-544.47M | USD | 1 Quarter |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-141.59M | USD | 1 Quarter |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$293.17M | USD | 1 Quarter |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.60B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.23B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.89B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.37B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.60B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.23B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.89B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.37B | USD | Point-in-time |
Stockholders Equity
26 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash dividends (in dollars per share) |
CommonStockDividendsPerShareCashPaid
|
$0.40 | USD | 1 Quarter |
| Cash dividends (in dollars per share) |
CommonStockDividendsPerShareCashPaid
|
$0.44 | USD | 1 Quarter |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.07B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-511.55M | USD | Point-in-time |
| Net income (loss) |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$378.71M | USD | 1 Quarter |
| Other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$25.47M | USD | 1 Quarter |
| Other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$44.16M | USD | 1 Quarter |
| Cash dividends |
DividendsCommonStockCash
|
$83.09M | USD | 1 Quarter |
| Cash dividends |
DividendsCommonStockCash
|
$91.10M | USD | 1 Quarter |
| Exercises of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$20.11M | USD | 1 Quarter |
| Exercises of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$58.22M | USD | 1 Quarter |
| Share-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$31.37M | USD | 1 Quarter |
| Share-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$48.32M | USD | 1 Quarter |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
$61.95M | USD | 1 Quarter |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
$129.78M | USD | 1 Quarter |
| Employee tax withholdings related to restricted share vesting |
EmployeeTaxWithholdingsRelatedToRestrictedShareVesting
|
$23.25M | USD | 1 Quarter |
| Employee tax withholdings related to restricted share vesting |
EmployeeTaxWithholdingsRelatedToRestrictedShareVesting
|
$9.60M | USD | 1 Quarter |
| Other |
StockholdersEquityOther
|
$910.00K | USD | 1 Quarter |
| Other |
StockholdersEquityOther
|
$331.00K | USD | 1 Quarter |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.07B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-511.55M | USD | Point-in-time |
Comprehensive Income
14 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$378.71M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$25.45M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$44.16M | USD | 1 Quarter |
| Other |
OtherComprehensiveIncomeOtherNetOfTax
|
- | USD | 1 Quarter |
| Other |
OtherComprehensiveIncomeOtherNetOfTax
|
$19.00K | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$25.47M | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$44.16M | USD | 1 Quarter |
| Total comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$212.04M | USD | 1 Quarter |
| Total comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$422.87M | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$9.66M | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$166.00K | USD | 1 Quarter |
| Comprehensive income attributable to AmerisourceBergen Corporation |
ComprehensiveIncomeNetOfTax
|
$211.87M | USD | 1 Quarter |
| Comprehensive income attributable to AmerisourceBergen Corporation |
ComprehensiveIncomeNetOfTax
|
$413.21M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.